The FDA has delayed granting full approval of Novavax's COVID-19 vaccine despite it being on track to be cleared until ...

Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...

Continuing to ask questions on an issue that has been answered multiple times, by multiple people, introduces doubt and anxiety. Our children deserve better.

Strokes caused by an artery tear are landing five times as many Americans in the hospital these days, a new study says.

Teenagers who spend more time on screens tend to get worse sleep, both in terms of sleep quality and duration, researchers reported Wednesday in the journal PLOS Global Public Health.

Over the last two months, the pharmaceutical industry has remained on the sidelines as Health and Human Services Secretary Robert F. Kennedy Jr. and Elon Musk’s Department of Government Efficiency ...

A top vaccine official at the FDA is stepping down, warning that vaccine misinformation is coloring the country’s top health decisions.

Dr. Marks was asked to leave and then subsequently wrote that he did not want to become “subservient to [Secretary Kennedy’s] misinformation and lies.” Peter Marks is not a hero of the resistance but ...

It comes on the heels of the FDA's top vaccine scientist Peter Marks' exit from the agency, which will be effective April 5.

The sudden resignation of Peter Marks, M.D., Ph.D., from the FDA branch that regulates biological products for humans ...

Clifford Lane, a 45-year veteran of the NIH and close confidant of Fauci as NIAID deputy director for clinical research, and NIAID microbiology and infectious diseases director Emily Erbelding, have ...

As the FDA’s top biologics official, Peter Marks oversaw regulation of cell and gene therapies. The departure of Marks and mass layoffs throughout the FDA raise concerns about the agency’s ability to ...